A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
Selective Adenosine A2A Agonists May Change Myocardial Perfusion Imaging
2021
Annals of Nuclear Cardiology
Preserved Fulltext
In recent years, the requirement for pharmacological stress myocardial perfusion imaging (SPECT) has increased, and adenosine stress testing is now the mainstream. Selective adenosine A2A receptor agonists will be applied clinically in the future. By selectively activating only A2A receptors, it can reduce complications such as bronchospasm, hypotension, and bradycardia, which have been problems with adenosine stress tests. In addition, since this drug can be administered in bolus injection, it
doi:10.17996/anc.21-00147
fatcat:lqjxqr37wvdklhzdikebcvm3la